| For: | Madir A, Grgurevic I, Tsochatzis EA, Pinzani M. Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges. World J Gastroenterol 2024; 30(4): 290-307 [PMID: 38313235 DOI: 10.3748/wjg.v30.i4.290] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i4/290.htm |
| Number | Citing Articles |
| 1 |
Ainur Doszhan, Niyaz Malayev, Abai Baigenzhin, Nina Tostanovskaya, Anuar Abdikarimov, Kristina Pavlova, Assyltay Nauryzbayeva, Balzhan Abzhaparova, Gulsara Imambaeva. Longitudinal Inpatient Trajectories After Splenic Artery Embolization in Cirrhosis: Real-World Evidence from Kazakhstan. Journal of Clinical Medicine 2026; 15(11) doi: 10.3390/jcm15114337
|
| 2 |
Francesca Schinzari, Manfredi Tesauro, Carmine Cardillo. Is endothelin targeting finally ready for prime time?. Clinical Science 2024; 138(11) doi: 10.1042/CS20240607
|
| 3 |
Y Sudheer Varma, Vijay Kumar, Ratnadeep Biswas, Vishnu Shankar Ojha, Divendu Bhushan, Ramesh Kumar, Rajeev Nayan Priyadarshi. Role of platelet counts to spleen length ratio and platelet-albumin to spleen length ratio as non-invasive predictors of esophageal varices in chronic liver disease patients: A cross-sectional study in Eastern India. Journal of Family Medicine and Primary Care 2025; 14(7) doi: 10.4103/jfmpc.jfmpc_2032_24
|
| 4 |
Shreya C. Pal, Mariana M. Ramírez-Mejía, Andrew P. Keaveny, Nahum Méndez-Sánchez. Non-invasive biomarkers for monitoring portal hypertension in metabolic dysfunction-associated steatotic liver disease (MASLD). Expert Review of Gastroenterology & Hepatology 2025; 19(9) doi: 10.1080/17474124.2025.2548526
|
| 5 |
Halima Righi, Fadia Bekhti-Sari, Sabri Ahmed Cherrak, Reda Bettioui, Dahbia Ines Dahmani, Ouarda Sariyah Ayachi, Bachir Bensenane, Ahmed Belloufa, Hafida Merzouk, Nassima Amal Mokhtari-Soulimane. Elucidating the effect of camel α-lactalbumin in modulating obesity-related metabolic disorders in an obese rat model. International Journal of Biological Macromolecules 2025; 295 doi: 10.1016/j.ijbiomac.2025.139693
|
| 6 |
Søren Møller, Sannia M.S. Sjöstedt, Lise Hobolth, Christian Mortensen, Nina Kimer. The pathophysiological role of portal hypertension in metabolic dysfunction–associated steatotic liver disease. Hepatology Communications 2025; 9(11) doi: 10.1097/HC9.0000000000000817
|
| 7 |
Francesco Santopaolo, Lucia Giuli, Brigida Eleonora Annicchiarico, Clelia Cavallo, Antonella Carcagnì, Andrea Contegiacomo, Antonio Gasbarrini, Roberto Iezzi, Maria Pallozzi, Francesca Romana Ponziani, Gianenrico Rizzatti, Rosa Talerico, Giulia Tripodi, Giulia Venturini, Alberto Larghi. Prognostic performance of endoscopic ultrasound-guided portal pressure gradient: preliminary results from the EVADIPP study. Endoscopy 2026; doi: 10.1055/a-2948-9632
|
| 8 |
Sahib Singh, Saurabh Chandan, Sumant Inamdar, Kambiz S. Kadkhodayan, Jahnvi Dhar, Jayanta Samanta, Antonio Facciorusso. EUS-Guided Vascular Interventions: Recent Advances. Journal of Clinical Medicine 2024; 13(16) doi: 10.3390/jcm13164835
|
| 9 |
Fahad S. Mohammed, Minzhi Xing, Michael Mohnasky, Andrew Caddell, Jack Felkner, Thomas Turner, Arjun Juneja, Nima Kokabi, Hyeon Yu, Chelsea Anderson, A. Sidney Barritt, Andrew M. Moon. External Validation of Laboratory-Based Models to Assess Portal Hypertension Severity in Patients with Compensated Chronic Liver Disease. Digestive Diseases and Sciences 2026; 71(10) doi: 10.1007/s10620-026-09993-5
|
| 10 |
Yunlin Huang, Yi Yu, Ying Wang, Yijie Qiu, Rui Cheng, Li Wei, Yi Dong. Quantitative liver ultrasound: current status and challenges. Ultrasonography 2026; 45(5) doi: 10.14366/usg.26148
|
| 11 |
Anja M. Fischer, Nazim Lechea, Harvey O. Coxson. This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol. Seminars in Liver Disease 2024; 44(02) doi: 10.1055/a-2334-8525
|
| 12 |
Wei Yan, Yixi Zhang, Lu Yang, Yuqin Jiang, Qin Yang, Lingyi Jiang, Haocheng Bian, Xiang Qin, Tingting Li, Yiyao Liu, Shun Li. Universal Pressure-Loading Device for Live-Cell Imaging under Sustained Physiological Mechanical Stress. Journal of Visualized Experiments 2026; (232) doi: 10.3791/70868
|
| 13 |
Yanqiu Li, Zihang Qiao, Jinze Li, Bingbing Zhu, Yu Lu, Ying Feng, Xianbo Wang. Relative change rate of liver stiffness measurements predicts the risk of liver decompensation in compensated advanced chronic liver disease. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01813-w
|
| 14 |
Yifan Lv, Bing Zhu, Dongze Li, Hua Tian, Shaoli You, Sa Lv, Fuchuan Wang, Yongping Yang, Huiguo Ding, Yifan Wu, Chengbin Dong, Yu Zhang, Fuquan Liu. Stratified analysis of the correlation between wedged hepatic venous pressure and portal venous pressure in patients with portal hypertension. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-80870-9
|
| 15 |
Femmy Nurul Akbar, Nikko Darnindro, Annisa Ayu Wardhani, Safira Rosiana Choirida, Shafa Nada Saphira, Griffith Ismed, Ida Ayu Made Kshanti, Syifa Mustika, Hari Hendarto. Diagnostic challenges of clinically significant portal hypertension in geriatric metabolic dysfunction-associated fatty liver disease: A case report. World Journal of Hepatology 2026; 18(2): 115063 doi: 10.4254/wjh.v18.i2.115063
|
| 16 |
Drew T Castleberry, Rupinder Mann, Benjamin Tharian, Ragesh Babu Thandassery. Endoscopic ultrasound in the management of complications related to cirrhosis- recent evidence. World Journal of Gastrointestinal Endoscopy 2025; 17(9): 108549 doi: 10.4253/wjge.v17.i9.108549
|
| 17 |
Qian-Qian Ma, Ling Wang, Si-Yuan Zhou, Bang-Le Zhang, Li- Shuang Hou. Construction of hepatic stellate cells-targeted nanosystem of verteporfin for the effective treatment of liver fibrosis through mechanical signal modulation. Nanotechnology 2026; 37(20) doi: 10.1088/1361-6528/ae6788
|
| 18 |
Zouhir Gadi, Wilhelmus J. Kwanten, Luisa Vonghia, Sven M. Francque. MASH to cirrhosis: bridging the gaps in MASLD management. Acta Clinica Belgica 2024; 79(6) doi: 10.1080/17843286.2025.2466011
|
| 19 |
|
| 20 |
Eric Markarian, Tien Dong, Arpan Patel, James H. Tabibian. Noninvasive Screening for High-Risk Esophageal Varices in Cirrhosis. Journal of Clinical Gastroenterology 2026; 60(7) doi: 10.1097/MCG.0000000000002378
|
| 21 |
Lampros Chrysavgis, Evangelos Cholongitas. From Single Agents to Synergy: Redefining Therapeutic Strategies in MASLD. International Journal of Molecular Sciences 2026; 27(18) doi: 10.3390/ijms27188368
|
| 22 |
Jiyang Zhang, Lingjun Liu, Xin Yu, Xiao Li, Zhongyou Li, Taoping Bai, Wentao Jiang. Asymmetric Sensitivity of Hepatic Venous Pressure Gradient to Portal and Sinusoidal Resistance: An In Vitro Experimental Study. Biosensors 2026; 16(8) doi: 10.3390/bios16080432
|
| 23 |
Shuang Gao, Beiyan Chen, Xin Chen, Qingping Shi, Mingli Shen, Jieru Han. The Mechano-Immune-Vascular Activation Loop: An Integrative Conceptual Framework for Positive Feedback in Hypertension. International Journal of Molecular Sciences 2026; 27(18) doi: 10.3390/ijms27188048
|
| 24 |
Qing Liu, Nan Ai, Rui Wang, Zhenbo Li, Yihan Liu, Lei Wu, Yuqin Zhao, Jing Yang. Hydroxysafflor yellow A attenuates microcirculatory disturbance in MAFLD via the EGFR/MAPK1 pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; doi: 10.1007/s00210-026-05980-9
|
| 25 |
Mohamed El-Kassas, Marwa Khalaf Hassan, Khalid Al-Naamani. Unraveling the link: diagnosing metabolic dysfunction-associated steatotic liver disease in the context of decompensated cirrhosis. Expert Review of Gastroenterology & Hepatology 2025; 19(3) doi: 10.1080/17474124.2025.2469267
|
| 26 |
Xin Tang, Wei-Hao Cai, Wei Mao, Long-Xin Xiong. Hepatocyte ischemia and hypoxia in liver cirrhosis progression: Pathophysiological roles and molecular mechanisms. World Chinese Journal of Digestology 2026; 34(7) doi: 10.11569/wcjd.v34.i7.541
Abstract(103) |
Core Tip(112) |
Full Article(HTML)(308)
|
Times Cited (0)
|
Total Visits (1613)
|
Open
|
| 27 |
Xiang Li, Xin Li, You Zheng, Qiong Hu, Changgu Zhou, Surong Ren, Weijuan Chen, Xiaojing He, Tianwu Chen, Dajing Guo, Jun Zhou. Four-dimensional flow MRI-based prediction of minimal hepatic encephalopathy in patients with liver cirrhosis. Abdominal Radiology 2026; 51(11) doi: 10.1007/s00261-026-05539-5
|
| 28 |
Rui Li, Xiaojuan Huang, Shengbiao Li, Tongtong Zhang. The role and mechanisms of the vascular microenvironment in metabolic dysfunction– associated fatty liver disease. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1916728
|
| 29 |
Katharina Endhardt, Juliane Friemel, Anne‐Laure Leblond, Daniela Lenggenhager, Beat Müllhaupt, Rainer Grobholz, Achim Weber. Lipidic obstruction of sinusoids (LOS): a potentially serious complication of steatotic liver disease. Histopathology 2026; doi: 10.1111/his.70309
|
| 30 |
A.A. Antonіv, L.V. Kanovska, N.A. Antoniv, L.V. Mikulets, Yu.M. Yarynych. Portal hypertension in metabolic dysfunction-associated steatotic liver disease: mechanisms of endothelial dysfunction, sinusoidal remodeling, and emerging therapeutic targets (review). INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2026; 22(7) doi: 10.22141/2224-0721.22.7.2026.1788
|
| 31 |
Diego Rojo, Alba Jiménez-Masip, Laura Pagès, Juan Bañares, Clara Sabiote, María Martínez-Gómez, Laia Aceituno, M. Serra Cusidó, M. Teresa Salcedo-Allende, Zyanya Calixto, Mònica Pons, Joan Genescà, Juan M. Pericàs. Assessment and management of portal hypertension in patients with MASLD: advances and caveats. Expert Review of Gastroenterology & Hepatology 2025; 19(8) doi: 10.1080/17474124.2025.2530605
|
| 32 |
Tamer A. Addissouky. Liver stiffness as a dynamic predictor of decompensation and mortality in alcohol-related liver disease. Discover Medicine 2024; 1(1) doi: 10.1007/s44337-024-00083-x
|
| 33 |
Roberta Chianetta, Lydia Giannitrapani, Alessio Giuseppe Lipari, Assunta Brunone, Claudia Cannizzo, Roberto Citarrella, Maurizio Soresi, Antonio Liguori, Nadia Panera, Filomena Morisco, Luca Miele, Anna Licata. Emerging Therapeutic Perspectives in Obese Patients with MASLD Leading to Compensated Advanced Chronic Liver Disease. Biomolecules 2026; 16(6) doi: 10.3390/biom16060797
|